Insider Transactions in Q2 2025 at Entrada Therapeutics, Inc. (TRDA)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
5 Am Ventures V, L.P. |
SELL
Open market or private sale
|
Indirect |
6,422
-0.58%
|
$38,532
$6.81 P/Share
|
|
Jun 30
2025
|
5 Am Ventures V, L.P. |
SELL
Open market or private sale
|
Direct |
18,578
-0.58%
|
$111,468
$6.81 P/Share
|
|
Jun 30
2025
|
Kush Parmar |
SELL
Open market or private sale
|
Indirect |
25,000
-0.58%
|
$150,000
$6.81 P/Share
|
|
Jun 27
2025
|
5 Am Ventures V, L.P. |
SELL
Open market or private sale
|
Indirect |
19,265
-1.7%
|
$115,590
$6.91 P/Share
|
|
Jun 27
2025
|
5 Am Ventures V, L.P. |
SELL
Open market or private sale
|
Direct |
55,735
-1.7%
|
$334,410
$6.91 P/Share
|
|
Jun 27
2025
|
Kush Parmar |
SELL
Open market or private sale
|
Indirect |
75,000
-1.7%
|
$450,000
$6.91 P/Share
|
|
Apr 03
2025
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,134
+8.45%
|
$22,268
$2.1 P/Share
|